Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gabriel R. Freitas"'
Autor:
Gabriel R. FREITAS, Cristiane Manoela SILVA, Kérilin Stancine ROCHA, Rodrigo Silveira PINTO, Marcos Valério SILVA, Wellington Barros DA SILVA, Diego GNATTA, Dyego Carlos ARAÚJO
Publikováno v:
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 15, Iss 4, Pp e1213-e1213 (2024)
Externí odkaz:
https://doaj.org/article/7e55381172c24389ba235d575354abed
Publikováno v:
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 12, Iss 3 (2021)
Objective: The purpose of this study was to review in a systematically way the studies that investigated the economic impact of clinical pharmacist services delivered to asthma individuals. Methods: A systematic survey was conducted in the PubMed, Sc
Externí odkaz:
https://doaj.org/article/be16fd77d4cf42b68cb1e541db326de6
Autor:
Taian M. Vieira, Thiago Lemos, Laura A. S. Oliveira, Carlos H. R. Horsczaruk, Gabriel R. Freitas, Fernanda Tovar-Moll, Erika C. Rodrigues
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Neuromuscular adaptations are well-reported in stroke survivors. The death of motor neurons and the reinnervation of residual muscle fibers by surviving motor neurons, for example, seem to explain the increased density of muscle units after stroke. I
Externí odkaz:
https://doaj.org/article/70a83402f00a40f0950eeb95c454868f
Autor:
Brayan V. Seixas, Gabriel R. Freitas
Publikováno v:
Pharmacy Practice, Vol 19, Iss 1, p 2168 (2021)
Background: Polypharmacy has become an increasingly public health issue as population age and novel drugs are developed. Yet, evidence on low- and middle-income countries (LMIC) is still scarce. Objective: This work aims to estimate the prevalence
Externí odkaz:
https://doaj.org/article/2443012bc79d48509d8585918d1592a5
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 31, Pp 99-103 (2009)
O AVC é o recordista em número de óbitos e a maior causa de incapacidade no Brasil. Apesar das inúmeras pesquisas realizadas ao longo dos últimos anos não há terapias farmacológicas adequadas para este quadro e, neste cenário, as terapias ce
Externí odkaz:
https://doaj.org/article/ba1d8763ee3c4e86a581f1c7158051f0
Autor:
Pedro Kurtz, Leonardo dos Santos Lourenço Bastos, Fernando G. Zampieri, Gabriel R. Freitas, Fernando A. Bozza, Marcio Soares, Jorge I.F. Salluh
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78766338989bccd777cfd1b57669794c
https://doi.org/10.2139/ssrn.4071507
https://doi.org/10.2139/ssrn.4071507
Autor:
Brayan V. Seixas, Gabriel R. Freitas
Publikováno v:
Pharmacy Practice
Pharmacy Practice (Granada) v.19 n.1 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
Pharmacy Practice, Vol 19, Iss 1, p 2168 (2021)
Pharmacy Practice (Granada) v.19 n.1 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)
Pharmacy Practice, Vol 19, Iss 1, p 2168 (2021)
Background: Polypharmacy has become an increasingly public health issue as population age and novel drugs are developed. Yet, evidence on low- and middle-income countries (LMIC) is still scarce. Objective: This work aims to estimate the prevalence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ad358100ece06570c09fe1c139fc976
https://doi.org/10.21203/rs.3.rs-54644/v1
https://doi.org/10.21203/rs.3.rs-54644/v1
